A cyclic dodecapeptide - Multiple-antigen peptide conjugate from the undecapeptidyl arch (from Arg168 to Cys178) of extracellular loop 2 in CCR5 as a novel human immunodeficiency virus type 1 vaccine

Journal of Virology

Volumn 75, Issue 23, 2001, Pages 11614-11620

  Misumi, S ^a   Nakajima, R ^a   Takamune, N ^a   Shoji, S ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ARGININE; ASPARTIC ACID; CDDR5 MAP; CHEMOKINE RECEPTOR CCR5; CYSTEINE; GLYCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN M; MACROPHAGE INFLAMMATORY PROTEIN; MONOCLONAL ANTIBODY; PEPTIDE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMOTAXIS; CONCENTRATION RESPONSE; CONJUGATE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONFORMATION;

AIDS VACCINES; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ARGININE; CHEMOTAXIS; CYSTEINE; FLOW CYTOMETRY; HELA CELLS; HIV ANTIGENS; HIV-1; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MEMBRANE FUSION; OLIGOPEPTIDES; RECEPTORS, CCR5; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 0035168319     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.23.11614-11620.2001     Document Type: Article

References (27)

1. CC chemokine receptor 5-mediated signaling and HIV-1 coreceptor activity share common structural determinants
2. Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines
3. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
4. Real-time monitoring of antigen-antibody recognition on a metal oxide surface by an optical grating coupler sensor
5. HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 coreceptor
6. Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles
7. + T cells
8. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study
9. Preparation of monoclonal antibodies: Strategies and procedures
10. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity
11. + cell clone 1-10 (MAGIC-5)
12. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression
13. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
14. CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 in vitro
15. Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains
16. Analysis by surface plasmon resonance of the influence of valence on the ligand binding affinity and kinetics of an anti-carbohydrate antibody
17. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5
18. Direct measurement of the substrate preference of uracil-DNA glycosylase
19. Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist
20. Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity
21. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
22. The second extracellular loop of CCR5 is the major determinant of ligand specificity
23. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist
24. Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line
25. Chemokine genes - Beating the odds
26. Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding
27. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk